Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Tolvaptan price, strengths & recalls

Pharmacies pay $353.29 for 30 tablets of Tolvaptan 15 mg tablet this week. 6 manufacturers make it. It has 1 recall on record, none ongoing. Its official label last changed on September 9, 2022.

Generic
Pharmacies pay$353.29for 30 tablets of 15 mg tablet-19.2% in 4 weeks
Fair cash price
$416.78
Strengths
1
Makers
6
Updated
Nov 11

Tolvaptan price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
15 mg tablet$11.78$353.29 / 30 tablets-19.2%-68.0%
30 mg tabletNot priced this week

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recalls1 recall on record, latest Apr 29, 2015

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for tolvaptan? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedSeptember 9, 2022
Version10 of 4
EffectiveSep 7, 2022
Read the label

These highlights do not include all the information needed to use TOLVAPTAN TABLETS safely and effectively. See full prescribing information for TOLVAPTAN TABLETS. TOLVAPTAN tablets, for oral use Initial U.S. Approval: 2009

This drug has a boxed warning

WARNING: (A) INITIATE AND RE-INITIATE IN A HOSPITAL AND MONITOR SERUM SODIUM (B) NOT FOR USE FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)

(A) Initiate and re-initiate in a hospital and monitor serum sodium

Tolvaptan tablets should be initiated and re-initiated in patients only in a hospital where serum sodium can be monitored closely.

Too rapid correction of hyponatremia (e.g., >12 mEq/L/24 hours) can cause osmotic demyelination resulting in dysarthria, mutism, dysphagia, lethargy, affective changes, spastic quadriparesis, seizures, coma and death. In susceptible patients, including those with severe malnutrition, alcoholism or advanced liver disease, slower rates of correction may be advisable.

(B) Not for use for autosomal dominant polycystic kidney disease (ADPKD)

Because of the risk of hepatotoxicity, tolvaptan should not be used for ADPKD outside of the FDA-approved REMS [see Contraindications (4)].

WARNING: (A) INITIATE AND RE-INITIATE IN A HOSPITAL AND MONITOR SERUM SODIUM (B) NOT FOR USE FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)

See full prescribing information for complete boxed warning.

(A) Initiate and re-initiate in a hospital and monitor serum sodium

Tolvaptan tablets should be initiated and re-initiated in patients only in a hospital where serum sodium can be monitored closely.

Too rapid correction of hyponatremia (e.g., >12 mEq/L/24 hours) can cause osmotic demyelination resulting in dysarthria, mutism, dysphagia, lethargy, affective changes, spastic quadriparesis, seizures, coma and death. In susceptible patients, including those with severe malnutrition, alcoholism or advanced liver disease, slower rates of correction may be advisable.

(B) Not for use for autosomal dominant polycystic kidney disease (ADPKD)

Because of the risk of hepatotoxicity, tolvaptan should not be used for ADPKD outside of the FDA-approved REMS (4)

Recent major changes (as listed on the label)

Warnings and Precautions (5.5, 5.7) 04/2021

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Generic makers
5 approved generic applications on the market

Tolvaptan questions

How much does tolvaptan cost without insurance?

Pharmacies pay about $353.29 for 30 tablets of tolvaptan 15 mg tablet ($11.78 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $416.78. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is tolvaptan in shortage?

No shortage is reported for tolvaptan right now. We check the national shortage list every day.

Has tolvaptan been recalled?

1 recall on record, none ongoing. Recalls name specific lots - check yours.

When did the tolvaptan label last change?

The official label was last updated on September 9, 2022 (version 10). See what changed.

Talk about tolvaptan

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.